NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹325 Cr | ₹309 Cr | ₹303 Cr | ₹273 Cr | ₹22 Cr |
What is the latest Net Current Assets ratio of NATH BIOGENES (INDIA) ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹325 Cr |
| Mar2024 | ₹309 Cr |
| Mar2023 | ₹303 Cr |
| Mar2022 | ₹273 Cr |
| Mar2013 | ₹22 Cr |
How is Net Current Assets of NATH BIOGENES (INDIA) Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹325 Cr | 5.01 | |
| Mar2024 | ₹309 Cr | 1.92 | |
| Mar2023 | ₹303 Cr | 10.94 | |
| Mar2022 | ₹273 Cr | 1,164.10 | |
| Mar2013 | ₹22 Cr | - | |
Compare Net Current Assets of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹317.3 Cr | 11.9% | 15.1% | 17.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,480.4 Cr | 3.9% | -4.3% | -14.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,735.7 Cr | 1.5% | 15% | -29.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,148.4 Cr | 4.4% | 21.6% | -8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,072.7 Cr | 5.4% | 21.1% | -14.5% | Stock Analytics | |
| INDO US BIOTECH | ₹219.4 Cr | 2.8% | 10.5% | -31.4% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 11.9% |
15.1% |
17.3% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses